{
    "clinical_study": {
        "@rank": "100978", 
        "acronym": "PROPHY", 
        "arm_group": [
            {
                "arm_group_label": "Antibiotics", 
                "arm_group_type": "Experimental", 
                "description": "trimethoprim-sulfamethoxazole oral suspension, 4 mg/kg (0.5 mL/kg) twice daily for 10 days"
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "placebo oral suspension, 0.5 mL/kg twice daily for 10 days"
            }
        ], 
        "brief_summary": {
            "textblock": "The primary purpose of this study is to determine whether routine use of prophylactic\n      (preventive) antibiotics is beneficial or unnecessary after hypospadias repair."
        }, 
        "brief_title": "Prophylactic Antibiotics or Placebo After Hypospadias Repair", 
        "completion_date": {
            "#text": "July 2022", 
            "@type": "Anticipated"
        }, 
        "condition": "Hypospadias", 
        "condition_browse": {
            "mesh_term": [
                "Hypospadias", 
                "Epispadias"
            ]
        }, 
        "detailed_description": {
            "textblock": "Participants in this multicenter, double-blind study are randomized to receive\n      trimethoprim-sulfamethoxazole or placebo for 10 days postoperatively. Short- and\n      intermediate-term results will be published after participants complete 6 months and 5 years\n      of follow-up, respectively."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  mid-to-distal shaft hypospadias\n\n          -  single-stage hypospadias repair with circumcision\n\n          -  length of urethral repair (urethroplasty) no greater than 20 mm\n\n          -  placement of an open-drainage urethral stent at the time of hypospadias repair, with\n             intended duration of stenting of 5-10 days post-operatively\n\n        Exclusion Criteria:\n\n          -  previous hypospadias or other penile surgery, including circumcision\n\n          -  prior adverse/allergic reaction or other contraindication to\n             trimethoprim-sulfamethoxazole\n\n          -  cross-reactivity of an existing medication with trimethoprim-sulfamethoxazole\n\n          -  HIV/AIDS, poorly controlled diabetes mellitus or other immunocompromising conditions\n\n          -  use of antibiotics within seven days prior to hypospadias repair\n\n          -  foreskin reconstruction at the time of hypospadias repair\n\n          -  prescription of oral antibiotics other than Study Medication at the time of\n             hypospadias repair"
            }, 
            "gender": "Male", 
            "healthy_volunteers": "No", 
            "maximum_age": "5 Years", 
            "minimum_age": "N/A"
        }, 
        "enrollment": {
            "#text": "630", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 21, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02096159", 
            "org_study_id": "LC/Uro-MF-01"
        }, 
        "intervention": [
            {
                "arm_group_label": "Antibiotics", 
                "intervention_name": "trimethoprim-sulfamethoxazole", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Placebo", 
                "intervention_name": "placebo", 
                "intervention_type": "Other"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Anti-Bacterial Agents", 
                "Antibiotics, Antitubercular", 
                "Sulfamethoxazole", 
                "Trimethoprim", 
                "Trimethoprim-Sulfamethoxazole Combination"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Hypospadias", 
            "Anti-Bacterial Agents"
        ], 
        "lastchanged_date": "April 13, 2014", 
        "link": {
            "url": "http://www.prophystudy.info/"
        }, 
        "location": [
            {
                "contact": {
                    "email": "mfaasse@luriechildrens.org", 
                    "last_name": "Mark A Faasse, MD", 
                    "phone": "312-227-6743"
                }, 
                "contact_backup": {
                    "email": "tmeyer@luriechildrens.org", 
                    "last_name": "Theresa Meyer, MS, RN, CPN", 
                    "phone": "(312) 227-6734"
                }, 
                "facility": {
                    "address": {
                        "city": "Chicago", 
                        "country": "United States", 
                        "state": "Illinois", 
                        "zip": "60611"
                    }, 
                    "name": "Ann & Robert H Lurie Children's Hospital of Chicago"
                }, 
                "investigator": [
                    {
                        "last_name": "Earl Y Cheng, MD", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Dennis B Liu, MD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Mark A Faasse, MD", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Toronto", 
                        "country": "Canada", 
                        "state": "Ontario", 
                        "zip": "M5G 1X8"
                    }, 
                    "name": "The Hospital for Sick Children"
                }, 
                "investigator": [
                    {
                        "last_name": "Walid A Farhat, MD", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Joseph M Gleason, MD", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": [
                "United States", 
                "Canada"
            ]
        }, 
        "number_of_arms": "2", 
        "official_title": "Trimethoprim-sulfamethoxazole vs. Placebo After Hypospadias Repair: a Multicenter, Double-blind, Randomized Trial", 
        "overall_contact": {
            "email": "mfaasse@luriechildrens.org", 
            "last_name": "Mark A Faasse, MD", 
            "phone": "(312) 227-6743"
        }, 
        "overall_contact_backup": {
            "email": "tmeyer@luriechildrens.org", 
            "last_name": "Theresa Meyer, MS, RN, CPN", 
            "phone": "(312) 227-6734"
        }, 
        "overall_official": [
            {
                "affiliation": "Ann & Robert H Lurie Children's Hospital of Chicago", 
                "last_name": "Earl Y Cheng, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Ann & Robert H Lurie Children's Hospital of Chicago", 
                "last_name": "Mark A Faasse, MD", 
                "role": "Study Director"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2017", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "measure": "postoperative infection", 
                "safety_issue": "No", 
                "time_frame": "up to 1 month"
            }, 
            {
                "description": "meatal stenosis; urethral stricture; urethrocutaneous fistula; dehiscence; urethral diverticulum", 
                "measure": "wound-healing complications", 
                "safety_issue": "No", 
                "time_frame": "up to 5 years"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02096159"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Ann & Robert H Lurie Children's Hospital of Chicago", 
            "investigator_full_name": "Earl Y Cheng, MD", 
            "investigator_title": "Head, Division of Urology", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "adverse drug reaction", 
                "safety_issue": "Yes", 
                "time_frame": "up to 14 days"
            }, 
            {
                "measure": "C. difficile colitis", 
                "safety_issue": "Yes", 
                "time_frame": "up to 6 months"
            }
        ], 
        "source": "Ann & Robert H Lurie Children's Hospital of Chicago", 
        "sponsors": {
            "collaborator": {
                "agency": "The Hospital for Sick Children", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Ann & Robert H Lurie Children's Hospital of Chicago", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}